NCT00189475View on ClinicalTrials.gov

Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Upper Respiratory Infection
Interventions
DRUG

Montelukast

DRUG

Placebo

Trial Locations (1)

15212

Allegheny General Hospital, Pittsburgh

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Deborah Gentile

OTHER

NCT00189475 - Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds | Biotech Hunter | Biotech Hunter